François Briand

1.9k total citations
45 papers, 1.1k citations indexed

About

François Briand is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, François Briand has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 19 papers in Molecular Biology and 18 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in François Briand's work include Cholesterol and Lipid Metabolism (17 papers), Drug Transport and Resistance Mechanisms (11 papers) and Liver Disease Diagnosis and Treatment (11 papers). François Briand is often cited by papers focused on Cholesterol and Lipid Metabolism (17 papers), Drug Transport and Resistance Mechanisms (11 papers) and Liver Disease Diagnosis and Treatment (11 papers). François Briand collaborates with scholars based in France, United States and Netherlands. François Briand's co-authors include Thierry Sulpice, Daniel J. Rader, Rémy Burcelin, Didier Grillot, Khadija Ouguerram, John S. Millar, Niels Nijstad, Uwe J.F. Tietge, Philippe Delerive and Jeffery T. Billheimer and has published in prestigious journals such as Circulation, Nature Communications and Gastroenterology.

In The Last Decade

François Briand

42 papers receiving 1.0k citations

Peers

Countries citing papers authored by François Briand

Since Specialization

Citations

This map shows the geographic impact of François Briand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Briand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Briand more than expected).

Fields of papers citing papers by François Briand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Briand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Briand. The network helps show where François Briand may publish in the future.

Co-authorship network of co-authors of François Briand

This figure shows the co-authorship network connecting the top 25 collaborators of François Briand. A scholar is included among the top collaborators of François Briand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Briand. François Briand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lanifibranor and semaglutide demonstrate multiple metabolic benefits in free-choice diet induced obese hamster models of MASH and MetALD 2025 ·European Journal of Pharmacology ·François Briand, Caroline Dubroca, Guillaume Wettstein, E. Grasset, Natália Martins Breyner, (unknown), Rana Assaly, Pierre Broqua, (unknown)	0
2	A Specific Collagen Hydrolysate Improves Postprandial Glucose Tolerance in Normoglycemic and Prediabetic Mice and in a First Proof of Concept Study in Healthy, Normoglycemic and Prediabetic Humans 2024 ·Food Science & Nutrition ·E. Grasset, François Briand, (unknown), Christiane Schön, Manfred Wilhelm, Benoît Cudennec, Rozenn Ravallec, (unknown), (unknown), Janne Prawitt, (unknown), Elien Gevaert	1
3	Molecular imaging of liver inflammation using an anti-VCAM-1 nanobody 2023 ·Nature Communications ·Maxime Nachit, Christopher Montemagno, (unknown), Mitra Ahmadi, François Briand, Sandrine Bacot, Nick Devoogdt, (unknown), Cathérine Ghezzi, Thierry Sulpice, Alexis Broisat, Isabelle Leclercq, Pascale Perret	19
4	Diet-Induced Obesity and NASH Impair Disease Recovery in SARS-CoV-2-Infected Golden Hamsters 2022 ·Viruses ·François Briand, Valentin Sencio, Cyril Robil, Séverine Heumel, Lucie Deruyter, Arnaud Machelart, (unknown), (unknown), Eik Hoffmann, (unknown), Oliver Domenig, (unknown), Virgile Richard, Vincent Prévot, Rubén Nogueiras, Isabelle Wolowczuk, F Pinet, Thierry Sulpice, François Trottein	10
5	Alteration of the gut microbiota’s composition and metabolic output correlates with COVID-19-like severity in obese NASH hamsters 2022 ·Gut Microbes ·Valentin Sencio, Nicolas Benech, Cyril Robil, Lucie Deruyter, Séverine Heumel, Arnaud Machelart, Thierry Sulpice, Antonin Lamazière, Corinne Grangette, François Briand, Harry Sokol, François Trottein	16
6	Elafibranor improves diet-induced nonalcoholic steatohepatitis associated with heart failure with preserved ejection fraction in Golden Syrian hamsters 2021 ·Metabolism ·François Briand, (unknown), (unknown), Natália Martins Breyner, (unknown), (unknown), Thierry Lesté-Lasserre, (unknown), Li Chen, (unknown), Virgile Richard, Rémy Burcelin, Caroline Dubroca, Thierry Sulpice	23
7	Ezetimibe Enhances Macrophage-to-Feces Reverse Cholesterol Transport in Golden Syrian Hamsters Fed a High-Cholesterol Diet 2020 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), (unknown), François Briand, Thierry Sulpice, Khadija Ouguerram	4
8	Liraglutide shows superior cardiometabolic benefits than lorcaserin in a novel free choice diet-induced obese rat model 2020 ·European Journal of Pharmacology ·François Briand, (unknown), (unknown), Caroline Dubroca, (unknown), Natália Martins Breyner, Rémy Burcelin, Thierry Sulpice	4
9	Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis 2019 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Thibaut Duparc, François Briand, (unknown), (unknown), Guillaume Combes, Souad Najib, Thierry Sulpice, Laurent O. Martinez	17
10	Nephropathy in diabetic db/db mice is accelerated by high protein diet and improved by the SGLT2 inhibitor dapagliflozin 2019 ·European Journal of Pharmacology ·(unknown), François Briand, Fredrik Wolfhagen Sand, Elisabeth D. Galsgaard, Henrik Søndergaard, Dorte Bratbo Sørensen, Thierry Sulpice	34
11	Evaluation of Antiatherogenic Properties of Ezetimibe Using³H-Labeled Low-Density-Lipoprotein Cholesterol and^99mTc-cAbVCAM1–5 SPECT in ApoE^−/−Mice Fed the Paigen Diet 2017 ·Journal of Nuclear Medicine ·Laurent Dumas, François Briand, (unknown), (unknown), Christopher Montemagno, Mitra Ahmadi, Sandrine Bacot, (unknown), Pascale Perret, Laurent Riou, Nick Devoogdt, Tony Lahoutte, Gilles Barone‐Rochette, Daniel Fagret, Cathérine Ghezzi, Thierry Sulpice, Alexis Broisat	19
12	Raising HDL with CETP inhibitor torcetrapib improves glucose homeostasis in dyslipidemic and insulin resistant hamsters 2014 ·Atherosclerosis ·François Briand, Bénédicte Prunet‐Marcassus, (unknown), (unknown), (unknown), Sylvie Sordello, Thierry Sulpice	13
13	High-Fat and Fructose Intake Induces Insulin Resistance, Dyslipidemia, and Liver Steatosis and Alters In Vivo Macrophage-to-Feces Reverse Cholesterol Transport in Hamsters 2012 ·Journal of Nutrition ·François Briand, (unknown), (unknown), Thierry Sulpice	39
14	Sitagliptin promotes macrophage‐to‐faeces reverse cholesterol transport through reduced intestinal cholesterol absorption in obese insulin resistant CETP‐apoB100 transgenic mice 2012 ·Diabetes Obesity and Metabolism ·François Briand, (unknown), Rémy Burcelin, Thierry Sulpice	19
15	Abstract 11835: An Alternative Method to Measure in vivo Reverse Cholesterol Transport in Hyperlipidemic Hamsters 2011 ·Circulation ·François Briand, (unknown), (unknown), Thierry Sulpice	1
16	Biliary Sterol Secretion is Required for Functional in vivo Reverse Cholesterol Transport 2009 ·Data Archiving and Networked Services (DANS) ·Niels Nijstad, Thomas Gautier, François Briand, Daniel J. Rader, (unknown)	2
17	Both the Peroxisome Proliferator‐Activated Receptor δ Agonist, GW0742, and Ezetimibe Promote Reverse Cholesterol Transport in Mice by Reducing Intestinal Reabsorption of HDL‐Derived Cholesterol 2009 ·Clinical and Translational Science ·François Briand, Snehal Naik, Ilia V. Fuki, John S. Millar, Colin H. Macphee, Max Walker, Jeffrey T. Billheimer, George H. Rothblat, Daniel J. Rader	63
18	Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model 2009 ·Journal of Lipid Research ·François Briand, (unknown), Agnès André, Didier Grillot, Marc Issandou, Khadija Ouguerram, Thierry Sulpice	30
19	Effects of atorvastatin on high‐density lipoprotein apolipoprotein A‐I metabolism in dogs 2006 ·European Journal of Clinical Investigation ·François Briand, T. Magot, Michel Krempf, Patrick Nguyen, Khadija Ouguerram	14
20	Metabolism of cholesterol ester of apolipoprotein B100‐containing lipoproteins in dogs: evidence for disregarding cholesterol ester transfer 2004 ·European Journal of Clinical Investigation ·(unknown), François Briand, Patrick Nguyen, Michel Krempf, T. Magot, Khadija Ouguerram	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact